CN104418767A - Demeclocycline extraction process - Google Patents

Demeclocycline extraction process Download PDF

Info

Publication number
CN104418767A
CN104418767A CN201310380480.4A CN201310380480A CN104418767A CN 104418767 A CN104418767 A CN 104418767A CN 201310380480 A CN201310380480 A CN 201310380480A CN 104418767 A CN104418767 A CN 104418767A
Authority
CN
China
Prior art keywords
cicloxin
extraction process
demeclocycline
filtrate
concentrated solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310380480.4A
Other languages
Chinese (zh)
Inventor
刘俭国
毛全贵
焦龙
孟新梅
祝立新
王九
唐慧慧
牛景丽
孟利沙
王媛
王雪洁
谢书琴
万丹
刘丽杰
王丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIANFANG PHARMACEUTICAL CO Ltd HENAN
Original Assignee
TIANFANG PHARMACEUTICAL CO Ltd HENAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANFANG PHARMACEUTICAL CO Ltd HENAN filed Critical TIANFANG PHARMACEUTICAL CO Ltd HENAN
Priority to CN201310380480.4A priority Critical patent/CN104418767A/en
Publication of CN104418767A publication Critical patent/CN104418767A/en
Pending legal-status Critical Current

Links

Abstract

The invention provides a demeclocycline extraction process which comprises the following technical steps: adding an antioxidant into demeclocycline fermentation liquor, adjusting the pH to 1.0-4.0 by an acid, micro-filtering to separate mycelia and other solid impurities, and decolorizing the filtrate; concentrating the decolorized filtrate by using a nanofiltration organic film to obtain a demeclocycline concentrated solution; adjusting the pH of the concentrated solution to 4.5-8.5 by an alkali, carrying out crystallization and sedimentation, and carrying out solid-liquid separation on precipitate to obtain a demeclocycline crude product; and refining the demeclocycline crude product by using a double salt method to obtain a demeclocycline hydrochloride finished product. Compared with the original solvent extraction process, the process provided by the invention avoids use of organic solvents or greatly reduces use of organic solvents, so that discharge of three wastes is less and the environmental pollution is reduced. The process is stable in product yield and quality and suitable for industrial production and has a very high practical value. The obtained product meets EP and USP standards.

Description

Cicloxin extraction process
Technical field
The present invention relates to the preparation of medicine, particularly relate to a kind of novel technology for extracting of cicloxin.
Background technology
Cicloxin, another name Demethylchlortetracycline, demethyl Uromycin etc., be the tetracycline antibiotics produced by streptomyces aureus fermentation, similar to duomycin for its antimicrobial spectrum of bulk drug, antibacterial effect is stronger than tsiklomitsin, stablizes than duomycin.Along with derivative Minocycline HCl and Tigecycline are gone on the market and the Persisting exploitation of other derivatives in succession, the market outlook of cicloxin are more and more wide.
Traditional cicloxin fermentative production extracting method is filter after cicloxin fermented liquid is carried out pre-treatment, sheet frame, filtrate uses N-BUTYL ACETATE and butanols to extract, then use hydrochloric acid to strip and concentrate recrystallize, oven dry obtains cicloxin hydrochloride, traditional technology uses a large amount of N-BUTYL ACETATEs and butanols, and two solvents all have very high water-soluble, so three waste discharge is serious, environmental treatment cost increases; And due to the complicacy of fermented liquid and organic solvent extraction limitation, cause extraction difficulty, quality product and yield are all subject to Different Effects.
Summary of the invention
The present invention is intended to overcome the above problems, and spy provides a kind of cicloxin extraction process, and it comprises following processing step;
A, in cicloxin fermented liquid, add oxidation inhibitor, through acid for adjusting pH=1.0-4.0, micro-filtration, isolates mycelium and other solid impurities, and filtrate is decoloured;
B, destainer concentrate through nanofiltration organic membrane, obtain cicloxin concentrated solution;
C, concentrated solution is regulated pH=4.5-8.5 through alkali, crystalline deposit, to precipitate after solid-liquid separation to obtain cicloxin crude product;
D, cicloxin double salt method to be refined, obtain cicloxin hydrochloride finished product.
Wherein antioxidant is 0.05-0.5wt% S-WAT, and wherein acid is hydrochloric acid or oxalic acid, and wherein use ceramic membrane to carry out micro-filtration, wherein filtrate is decoloured through decolorizing resin.
Wherein nanofiltration organic membrane molecular weight cut-off is 100-500 dalton, and wherein alkali is NaOH solution or the ammoniacal liquor of 0.1-2M.
Wherein cicloxin uses urea double salt method or calcium magnesium double salt method to refine.
Compared with traditional solvent extraction method, the present invention uses ceramic membrane filter, resin decolorization, organic membrane filter concentrated, then NaOH solution or ammoniacal liquor is directly used by concentrated solution to regulate pH to carry out crystalline deposit, re-use urea double salt method or calcium magnesium double salt method carries out being refined into cicloxin hydrochloride, thus avoid or greatly reduce with an organic solvent, greatly reduce environmental pollution, thus produce good economic benefit and social benefit.And decolouring is concentrated is physical means, and quality product and yield all have stable guarantee.
Embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment one
By the fermented liquid containing 6.0g/L cicloxin 35 liters, adjust the temperature to 5-10 DEG C and add 0.05wt% S-WAT 35g, adjust the temperature to 10 DEG C, oxalic acid is used to regulate pH=1.5 ± 0.2, stir 20 minutes, use Nanjing for a long time my company's ceramic membrane filter, pottery membrane flux 30 ls/h; Obtain filtrate 70 liters;
Filtrate is crossed 122 resins, flow velocity 2BV/h, use the tap water top of pH=6.8-7.0 to wash 0.5 hour after completing, obtain destainer 72 liters;
Destainer being crossed molecular weight cut-off is 150 GE company of daltonian U.S. organic nanofiltration membrane assemblies, pressure 1.5mpa, and temperature keeps 5-10 DEG C; Obtain concentrated solution 4 liters;
By under concentrated solution agitation condition, regulate temperature 5-8 DEG C, use the ammoniacal liquor of 0.1M to regulate pH=6.5 ± 0.2, be precipitated suspension, continue stirring 30 minutes, leave standstill 30 minutes, solid-liquid separation obtains cicloxin crude product;
Used by cicloxin crude product urea double salt method to refine to obtain cicloxin finished product, dry to obtain cicloxin hydrochloride 152g, total recovery 72.38%; Finished product censorship meets EP, USP standard.
Embodiment two
By the fermented liquid containing 7.5g/L cicloxin 30 liters, add 0.5wt% S-WAT 150g, adjust the temperature to 5-10 DEG C, hydrochloric acid is used to regulate pH=2.5 ± 0.2, stir 20 minutes, use Xiamen three to reach company's ceramic membrane filter, pottery membrane flux 24.5 ls/h; Obtain filtrate 65 liters;
Filtrate is crossed LX-200 resin decolorization, flow velocity 3BV/h, use the tap water top of pH=6.8-7.0 to wash 0.5 hour after completing, obtain destainer 70 liters;
Destainer being crossed molecular weight cut-off is 150 GE company of daltonian U.S. organic nanofiltration membrane assemblies, pressure 1.5mpa, and temperature keeps 5-10 DEG C; Obtain concentrated solution 3.8 liters;
By under concentrated solution agitation condition, regulate temperature 5-8 DEG C, use the NaOH aqueous solution of 2M to regulate pH=8.2 ± 0.2, be precipitated suspension, continue stirring 30 minutes, leave standstill 30 minutes, solid-liquid separation obtains cicloxin crude product;
Used by cicloxin crude product urea double salt method to refine to obtain cicloxin finished product, dry to obtain cicloxin hydrochloride 166g, total recovery 73.78%; Finished product censorship meets EP, USP standard.
Embodiment three
By the fermented liquid containing 5.8g/L cicloxin 30 liters, adjust the temperature to 5-10 DEG C, add 0.1wt% S-WAT 30g, oxalic acid is used to regulate pH=3.8 ± 0.2, stir 20 minutes, use Nanjing for a long time my company's ceramic membrane filter, pottery membrane flux 28.5 ls/h; Obtain filtrate 70 liters;
Filtrate is crossed ROHM AND HAAS decolorizing resin, flow velocity 4BV/h, use the tap water top of pH=6.8-7.0 to wash 0.5h after completing, obtain destainer 75 liters;
Destainer being crossed molecular weight cut-off is 100 GE company of daltonian U.S. organic nanofiltration membrane assemblies, pressure 1.8mpa, and temperature keeps 5-10 DEG C; Obtain concentrated solution 4.5 liters;
By under concentrated solution agitation condition, regulate temperature 5-8 DEG C, use the ammoniacal liquor of 1M to regulate pH=4.8 ± 0.2, be precipitated suspension, continue stirring 30 minutes, leave standstill 30 minutes, solid-liquid separation obtains cicloxin crude product;
Used by cicloxin crude product calcium magnesium double salt method to refine to obtain cicloxin finished product, dry to obtain cicloxin hydrochloride 127g, total recovery 72.98%; Finished product censorship meets EP, USP standard.

Claims (8)

1. a cicloxin extraction process, is characterized in that comprising following processing step;
A, in cicloxin fermented liquid, add oxidation inhibitor, through acid for adjusting pH=1.0-4.0, micro-filtration, isolates mycelium and other solid impurities, and filtrate is decoloured;
B, destainer concentrate through nanofiltration organic membrane, obtain cicloxin concentrated solution;
C, concentrated solution is regulated pH=4.5-8.5 through alkali, crystalline deposit, to precipitate after solid-liquid separation to obtain cicloxin crude product;
D, cicloxin double salt method to be refined, obtain cicloxin hydrochloride finished product.
2. cicloxin extraction process as claimed in claim 1, wherein antioxidant is 0.05-0.5wt% S-WAT.
3. cicloxin extraction process as claimed in claim 1, wherein acid is hydrochloric acid or oxalic acid.
4. cicloxin extraction process as claimed in claim 1, wherein carries out micro-filtration by ceramic membrane.
5. cicloxin extraction process as claimed in claim 1, wherein the molecular weight cut-off of nanofiltration organic membrane is 100-500 dalton.
6. cicloxin extraction process as claimed in claim 1, wherein alkali is NaOH solution or the ammoniacal liquor of 0.1-2M.
7. cicloxin extraction process as claimed in claim 1, wherein cicloxin uses urea double salt method or calcium magnesium double salt method to refine.
8. cicloxin extraction process as claimed in claim 1, wherein filtrate is decoloured through decolorizing resin.
CN201310380480.4A 2013-08-28 2013-08-28 Demeclocycline extraction process Pending CN104418767A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310380480.4A CN104418767A (en) 2013-08-28 2013-08-28 Demeclocycline extraction process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310380480.4A CN104418767A (en) 2013-08-28 2013-08-28 Demeclocycline extraction process

Publications (1)

Publication Number Publication Date
CN104418767A true CN104418767A (en) 2015-03-18

Family

ID=52968976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310380480.4A Pending CN104418767A (en) 2013-08-28 2013-08-28 Demeclocycline extraction process

Country Status (1)

Country Link
CN (1) CN104418767A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108147976A (en) * 2016-12-06 2018-06-12 上海医药工业研究院 A kind of extracting method Ledermycined
CN108191692A (en) * 2017-12-25 2018-06-22 安徽永生堂药业有限责任公司 A kind of process for separation and purification of tetracycline antibiotics
CN114848599A (en) * 2022-06-09 2022-08-05 驻马店华中正大有限公司 High-stability aureomycin premix and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3375276A (en) * 1963-06-24 1968-03-26 Squibb & Sons Inc Method for preparing tetracycline products
US3433709A (en) * 1965-12-07 1969-03-18 American Cyanamid Co Biological transformation of alpha-6-deoxytetracyclines to tetracyclines
CN1590368A (en) * 2003-09-04 2005-03-09 华北制药集团有限责任公司 Recovery method of demeclocy cline hydrochloride crystal mother liquor
CN102731340A (en) * 2011-04-15 2012-10-17 河南天方药业股份有限公司 Preparation method of demethyl aureomycin hydrochloride

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3375276A (en) * 1963-06-24 1968-03-26 Squibb & Sons Inc Method for preparing tetracycline products
US3433709A (en) * 1965-12-07 1969-03-18 American Cyanamid Co Biological transformation of alpha-6-deoxytetracyclines to tetracyclines
CN1590368A (en) * 2003-09-04 2005-03-09 华北制药集团有限责任公司 Recovery method of demeclocy cline hydrochloride crystal mother liquor
CN102731340A (en) * 2011-04-15 2012-10-17 河南天方药业股份有限公司 Preparation method of demethyl aureomycin hydrochloride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
褚志义等: "《生物合成药物学》", 31 May 1991 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108147976A (en) * 2016-12-06 2018-06-12 上海医药工业研究院 A kind of extracting method Ledermycined
CN108147976B (en) * 2016-12-06 2020-11-10 上海医药工业研究院 Extraction method of demethylated aureomycin
CN108191692A (en) * 2017-12-25 2018-06-22 安徽永生堂药业有限责任公司 A kind of process for separation and purification of tetracycline antibiotics
CN114848599A (en) * 2022-06-09 2022-08-05 驻马店华中正大有限公司 High-stability aureomycin premix and preparation method thereof
CN114848599B (en) * 2022-06-09 2023-10-13 驻马店华中正大有限公司 High-stability aureomycin premix and preparation method thereof
WO2023236507A3 (en) * 2022-06-09 2024-02-01 驻马店华中正大有限公司 Highly stable chlortetracycline premix and preparation method therefor

Similar Documents

Publication Publication Date Title
CN102976923B (en) New process for extracting lactic acid from lactic acid fermentation liquid
CN108822163B (en) Comprehensive cyclic production method of D-glucosamine hydrochloride
CN102746348A (en) Method for separation of lincomycin
CN109180749B (en) Method for preparing high-purity N-acetylneuraminic acid hydrate by using supersaturation crystallization method
CN103102384B (en) Method for extracting high-purity ursolic acid from rosemary
CN104418767A (en) Demeclocycline extraction process
CN109081844B (en) Method for extracting spectinomycin from fermentation culture
WO2018192529A1 (en) Method for preparing s-abscisic acid
CN110790805A (en) Method for extracting chenodeoxycholic acid from pig bile paste
CN102603478B (en) Method for separating and purifying erythritol from mother liquid obtained after repeated crystallization of erythritol
CN101407533B (en) Method for producing abomacetin rhodanate
CN113583064B (en) Process method for producing rebaudioside B by high-temperature pyrolysis method
CN109553645B (en) Method for extracting low-content erythromycin A in fermentation solution
CN107383135A (en) The method that β thymidines are isolated and purified from zymotic fluid
CN111269181B (en) Method and device for purifying sinomenine hydrochloride
CN104497076A (en) Preparation purification method for high-purity geniposide
CN107129456B (en) Production process for extracting L-tryptophan from fermentation liquor
CN103012509B (en) Method of separating and purifying sucrose-6-acetate mother liquor by salt fractionation
CN113429283B (en) Method for recovering phenylacetic acid from medical wastewater
CN112047961B (en) Method for separating and crystallizing 6-aminopenicillanic acid from penicillin enzymolysis liquid
CN103058858A (en) Method for extracting high-purity carnosic acid from rosemary
CN110452275B (en) Preparation method of high-purity kasugamycin
CN110606844B (en) Mupirocin purification method
CN104151275B (en) The preparation method of Andrographolide compound
CN107586310B (en) Extraction process of flavomycin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150318